Financial statements Biovena
Balance sheet data of BIOVENA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|---|
| Total assets | 2 376 265,35 | 2 400 499,78 | 2 732 456,57 | 4 561 788,90 | 6 247 989,06 |
| A. Fixed assets | 1 250 829,70 | 1 149 635,88 | 1 062 971,60 | 3 013 887,56 | 4 884 926,33 |
| B. Current assets | 1 125 435,65 | 1 250 863,90 | 1 669 484,97 | 1 547 901,34 | 1 363 062,73 |
| C. Share capital contributions (basic funds) | - | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | - | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 2 376 265,35 | 2 400 499,78 | 2 732 456,57 | 4 561 788,90 | 6 247 989,06 |
| A. Equity | 829 922,78 | 859 968,90 | 971 571,56 | 1 156 976,32 | 2 094 216,85 |
| B. Liabilities and provisions for liabilities | 1 546 342,57 | 1 540 530,88 | 1 760 885,01 | 3 404 812,58 | 4 153 772,21 |
| I. Long-term liabilities | 450 277,63 | 343 870,03 | 253 946,10 | 133 381,44 | 2 757 033,79 |
| II. Short-term liabilities | 1 055 324,01 | 1 196 660,85 | 1 506 938,91 | 3 271 431,14 | 1 396 738,42 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.